Clinical Trials Update: May 18, 2005
Vaccines Insomnia Pregnancy
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
The Vanderbilt HIV Vaccine Program needs healthy, uninfected adults (ages 18-50) from all walks of life to help find a vaccine to prevent HIV infection.
There is no risk of HIV infection from the vaccine. Volunteers must be available locally for 12-18 months, and they will be compensated.
The research site is in Nashville, Tenn.
A nationwide research study of an investigational medication for insomnia is currently underway.
You might qualify for this study if you are 18-to-64 years of age, you have trouble falling asleep and your insomnia has effects on your daytime functioning.
Qualified participants will receive study drug and study-related physician visits at no charge.
The research site is in Lafayette, Calif.
The purpose of this study is to evaluate the effect of etanercept when used in the first trimester of pregnancy with respect to major structural birth defects of newborns. This is an observational study only -- no investigational product is used.
Eligible subjects will be pregnant women residing in the United States or Canada who have had any exposure to etanercept for treatment of rheumatoid arthritis (RA), juvenile RA, ankylosing spondylitis (AS), psoriatic arthritis (PsoA) or psoriasis (PsO) at any time during the first trimester of pregnancy. This is defined as the period between the first day of the last menstrual period (i.e., within two weeks of conception) up to and including the 12th week after the first day of the last menstrual period.
The research site is in San Diego.
Copyright 2005 CenterWatch. All rights reserved.